Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Making the News

 

MedEuropa acquisition heralds start of PE radiotherapy consolidation spree

The fragmented German radiotherapy market is starting to pique the interest of private equity, as many doctors reach retirement age. Pan-EU platform MedEuropa has acquired a three-centre group in the northwest, and CEO Ralph Hefti tells HBI that its model of co-investing alongside doctors is likely to win out consolidation efforts.
July 2, 2021

Mubadala and GIC in talks to buy Spanish REIT

Mubadala and GIC, the sovereign wealth funds of Abu Dhabi and Singapore, are in talks for a joint takeover of Spanish REIT Healthcare Activos Yield just nine months after it listed in Paris. 
July 1, 2021

Sovereign wealth funds big Asia-Pacific plays

Sovereign wealth funds are making some big entrances and exits in the Asia-Pacific with bids closing in QIC-owned oncology player Icon Group and Singapore's GIC acquiring a minority stake in Sunway hospital group Sunway Healthcare.
July 1, 2021

EMC plans Moscow IPO

Russia's second-largest healthcare operator by revenue, European Medical Center (EMC), has announced an intention to float in Moscow but will not be raising any proceeds from the process.
June 28, 2021

Europe’s telehealth consolidators explain their M&A

Acquisitions in the European telehealth space are ramping up this year thanks to some mid-sized consolidation plays. HBI speaks to the CEOs of the buying parties: Ranjan Singh from HealthHero and Murray Ellender from eConsult. 
June 17, 2021

Mubadala Health diversifies with $800m UEMedical deal

Mubadala Health, the integrated health network of sovereign investor Mubadala, has added speciality fertility and women's health services to its network and expanded into Saudi with the acquisition of UEMedical. It now claims to be the largest IVF provider in the region.
June 17, 2021

Private players swoop on national hotlines

Outpatient group Gajda-Med has won Poland's multi-million euro contract to deliver first-contact telehealth services for the Polish NHS. It follows a recent trend of private sector companies moving to work on national hotlines, including in Sweden and Switzerland, and it is very controversial where operators already own physical clinics.
June 10, 2021

Life Healthcare soars 17% on aducanumab’s FDA approval

The first FDA approval for an Alzheimer's drug in 20 years, aducanumab, sent the share price of South African and European hospital/imaging group Life Healthcare soaring 17%. The group manufacturers one of only three amyloid tracers for PET-CT diagnosis of the disease and is also the largest for-profit provider of PET-CT scans in Europe.
June 10, 2021
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us